Drug-screening in AML at Relapse for Targeted Treatment
Clinical trial NCT05732688 · COMPLETED
Trial details
- NCT number
- NCT05732688
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2024-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.